ACLARIS THERAPEUTICS INC
ACRS·00461U105·US·Common Stock·Healthcare - Biotechnology-13D/G
ACRS (ACLARIS THERAPEUTICS INC) is held by 88 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($27.8M), RA CAPITAL MANAGEMENT, L.P. ($25.5M), VANGUARD CAPITAL MANAGEMENT LLC ($19.4M). Net institutional sentiment: Mixed.
88
Holders
(10 Elite)
$200M
Total Value
55% (87)
Consensus
48 buying - 39 selling
13F: Insider & Congress:
Who's Trading
ActivistVOVivo Opportunity Fund Holdings, L.P.4.3%May 12, 2026
InsiderHWHall Jesse WayneExercise 36K shMay 1, 2026
InsiderHWHall Jesse WayneTax 9K shMay 1, 2026
ActivistBIBML Investment Partners, L.P.9.9%Apr 27, 2026
InsiderLMLeonard Braden MichaelSell $1.4MApr 23, 2026
ActivistDTDeep Track Capital, LP7.0%Mar 17, 2026
ActivistBIBiosion, Inc.9.4%Jan 9, 2026
Showing 1-20 of 95
1 / 5
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer